Edico raises $22M in series B

Edico Genome Inc. (San Diego, Calif.) raised $22 million in a series B financing led by new investor Dell Technologies Capital, the venture arm of Dell Technologies Inc. (NYSE:DVMT). Existing investors Qualcomm Ventures, Axon Ventures and board member Greg Lucier also participated.

Edico markets a platform based on its DRAGEN Bio-IT processor, which is designed to speed analysis of genomic sequencing data without sacrificing accuracy. It said the system can perform whole genome analyses inexpensively in 20 minutes or less with high accuracy. It has partnerships with Dell, Intel Corp. (NASDAQ:INTC) and the Amazon Web Services subsidiary of Amazon.com Inc. (NASDAQ:AMZN) (see BioCentury, July 21, 2014)...